New lifeline for patients with inoperable neuroendocrine cancers

22 Mar 2016


New drug Lutathera significantly lowers the risk for disease progression or death for patients with advanced midgut neuroendocrine tumours, according to a study presented at the 13th annual ENETS conference.

Medical News Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story